#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14208	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2084	677.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1466	1466	C	865	C	803	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14208	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2084	677.0	0	HET	.	.	.	C1450T	.	1450	1450	C	1732	1732	C	813	C,T	619,146	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25494	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3568	711.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1697	1697	A	900	A	840	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25494	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3568	711.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2331	2331	C	795	C,T,G	745,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25494	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3568	711.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2405	2405	A	822	A	769	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25494	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3568	711.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2957	2957	C	805	C,T	746,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25494	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3568	711.9	0	HET	.	.	.	A1148AT,ATT	.	1148	1148	A	1508	1508	A	844	AT,ATT	629,163	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25494	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3568	711.9	0	HET	.	.	.	T695C	.	695	695	T	1055	1055	T	758	T,C	544,172	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	539	27628	blaTEM	861	861	99.88	blaTEM.l6.c30.ctg.1	1567	1755.3	0	.	p	.	0	M180T	NONSYN	538	540	ATG	877	879	ACG	2658;2654;2645	A;C,A,G;G,A	2473;2491,1,1;2469,1	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1998	folP	855	855	100.0	folP.l15.c4.ctg.1	1681	118.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1089	1091	AGC	211;213;211	A;G;C	201;200;198	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5306	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3384	156.2	1	SNP	p	S91F	1	.	.	271	273	TTC	569	571	TTC	166;167;171	T;T;C	157;156;163	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5306	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3384	156.2	1	SNP	p	G95N	0	.	.	283	285	GGC	581	583	GGC	168;169;168	G,T;G;C,G	159,1;160;157,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5306	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3384	156.2	1	SNP	p	D95G	1	.	.	283	285	GGC	581	583	GGC	168;169;168	G,T;G;C,G	159,1;160;157,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	531	1522	mtrR	633	633	98.74	mtrR.l15.c30.ctg.1	1438	105.5	0	.	p	.	0	A39T	NONSYN	115	117	GCC	557	559	ACC	171;172;173	A,G;C;C	156,1;160;160	.	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	531	1522	mtrR	633	633	98.74	mtrR.l15.c30.ctg.1	1438	105.5	0	.	p	.	0	S179fs	FSHIFT	535	535	T	976	976	C	185	C	176	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	996	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	1044	95.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4960	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2955	167.4	0	.	p	.	0	E91G	NONSYN	271	273	GAG	598	600	GGG	203;200;200	G;G,A;G,T	193;190,1;190,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4960	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2955	167.4	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1630	1632	GCA	197;197;195	G,C;C;A,T	182,1;170;171,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4960	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2955	167.4	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2113	2115	ATT	216;216;216	A;T;T	199;202;202	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4960	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2955	167.4	1	SNP	p	D86N	0	.	.	256	258	GAC	583	585	GAC	213;213;210	G;A;C	203;196;200	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4960	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2955	167.4	1	SNP	p	S87I	0	.	.	259	261	AGT	586	588	AGT	209;207;208	A,G;G;T	196,1;194;195	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4960	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2955	167.4	1	SNP	p	S87R	0	.	.	259	261	AGT	586	588	AGT	209;207;208	A,G;G;T	196,1;194;195	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4960	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2955	167.4	1	SNP	p	S87W	0	.	.	259	261	AGT	586	588	AGT	209;207;208	A,G;G;T	196,1;194;195	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4960	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2955	167.4	1	SNP	p	S88P	0	.	.	262	264	TCC	589	591	TCC	208;206;207	TCC,TC;C;C	195,1;195;195	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4266	parE	1986	1986	99.9	parE.l15.c17.ctg.1	2657	159.9	0	.	p	.	0	V89A	NONSYN	265	267	GTC	538	540	GCC	198;202;201	G;C;C	185;191;186	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4266	parE	1986	1986	99.9	parE.l15.c17.ctg.1	2657	159.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1501	1503	GGC	221;221;217	G;G;C	205;206;203	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.002	penA.2.002	1	1	27	3836	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2334	163.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1227	1229	GCA	187;184;184	G;C;A	169;170;174	penA.2.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3836	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2334	163.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1230	1232	ATC	189;189;190	A;T;C	178;179;180	penA.2.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3836	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2334	163.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1242	1244	GTG	184;186;190	G;T;G	171;167;176	penA.2.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3836	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2334	163.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1242	1244	GTG	184;186;190	G;T;G	171;167;176	penA.2.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3836	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2334	163.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1746	1748	ACC	209;206;207	A;C;C	184;189;186	penA.2.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3836	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2334	163.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1800	1802	GCG	196;195;196	G;C;G	178;160;171	penA.2.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3836	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2334	163.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1800	1802	GCG	196;195;196	G;C;G	178;160;171	penA.2.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3836	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2334	163.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1923	1925	GGC	154;152;153	G;G;C	140;138;141	penA.2.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3836	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2334	163.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1932	1934	GGC	148;149;148	G;G;C	134;130;135	penA.2.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3836	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2334	163.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1950	1952	CCG	132;133;132	C;C;G	104;105;99	penA.2.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	5960	ponA	2397	2397	99.87	ponA.l15.c4.ctg.1	3102	191.4	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1538	1540	ACG	247;248;247	A;C;G	225;232;230	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2376	porA	1146	1146	99.56	porA.l15.c17.ctg.1	1649	142.4	0	.	p	.	0	S22G	NONSYN	64	66	AGC	311	313	GGC	173;173;174	G;G;C	157;157;160	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2376	porA	1146	1146	99.56	porA.l15.c17.ctg.1	1649	142.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	493	493	C	194	C	178	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2850	porB1a	984	984	99.9	porB1a.l15.c30.ctg.1	1568	181.1	0	.	p	.	0	G41R	NONSYN	121	123	GGA	561	563	AGA	251;251;252	A;G;A	234;233;234	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10440	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4864	213.9	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2073	2075	CAT	205;205;200	C;A;T	196;197;191	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1202	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	943	125.9	1	SNP	p	V57M	1	.	.	169	171	ATG	462	464	ATG	251;255;253	A;T;G	241;244;242	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	27	11424	tetM	1920	1920	100.0	tetM.l15.c17.ctg.1	2459	460.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Tetracycline resistance
